Raghuvanshi Pharma Private Limited

Renocrit Injection is a medication used primarily to treat anemia, particularly anemia caused by chronic kidney disease (CKD) or chemotherapy. It contains the active ingredient Erythropoietin, a synthetic form of a natural hormone produced by the kidneys that stimulates red blood cell production.

• Brand Name: Renocrit Injection

• Generic Name: Erythropoietin

• Common Strengths: 2000 IU, 4000 IU, 6000 IU, 10000 IU (varies by manufacturer)

• Route of Administration: Intravenous (IV) or Subcutaneous (SubQ)

• Manufacturer: Often produced by Indian pharmaceutical companies (e.g., Zydus Cadila), but brands may vary.

• Treats anemia in chronic kidney disease (both dialysis and non-dialysis patients)

• Manages anemia in cancer patients receiving chemotherapy

• May be used to reduce the need for blood transfusions before surgery

Renocrit stimulates the bone marrow to produce more red blood cells by mimicking the function of natural erythropoietin. This improves oxygen delivery to tissues and reduces symptoms of anemia like fatigue and weakness.